title: ErbB3-dependent motility and intravasation in breast cancer metastasis.
abstract: A better understanding of how epidermal growth factor receptor family members (ErbBs) contribute to metastasis is important for evaluating ErbB-directed therapies. Activation of ErbB3/ErbB2 heterodimers can affect both proliferation and motility. We find that increasing ErbB3-dependent signaling in orthotopic injection models of breast cancer can enhance intravasation and lung metastasis with no effect on primary tumor growth or microvessel density. Enhanced metastatic ability due to increased expression of ErbB2 or ErbB3 correlated with stronger chemotaxis and invasion responses to heregulin beta1. Suppression of ErbB3 expression reduced both intravasation and metastasis. A human breast cancer tumor tissue microarray showed a significant association between ErbB3 and ErbB2 expression and metastasis independent of tumor size. These results indicate that ErbB3-dependent signaling through ErbB3/ErbB2 heterodimers can contribute to metastasis through enhancing tumor cell invasion and intravasation in vivo and that ErbB-directed therapies may be useful for the inhibition of invasion independent of effects on tumor growth.
authors.affiliation: Department of Anatomy and Structural Biology, Albert Einstein College of Medicine, 1300 Morris Park Avenue, Bronx, NY 10801, USA.
authors.forename: Chengsen
authors.initials: C
authors.lastname: Xue
authors.forename: Fubo
authors.initials: F
authors.lastname: Liang
authors.forename: Radma
authors.initials: R
authors.lastname: Mahmood
authors.forename: Magalis
authors.initials: M
authors.lastname: Vuolo
authors.forename: Jeffrey
authors.initials: J
authors.lastname: Wyckoff
authors.forename: Hong
authors.initials: H
authors.lastname: Qian
authors.forename: Kun-Lin
authors.initials: KL
authors.lastname: Tsai
authors.forename: Mimi
authors.initials: M
authors.lastname: Kim
authors.forename: Joseph
authors.initials: J
authors.lastname: Locker
authors.forename: Zhong-Yin
authors.initials: ZY
authors.lastname: Zhang
authors.forename: Jeffrey E
authors.initials: JE
authors.lastname: Segall
mesh_terms: D000818:Animals; D001943:Breast Neoplasms / Q000378:metabolism* / Q000473:pathology*; D045744:Cell Line, Tumor; D002465:Cell Movement / Q000502:physiology*; D005260:Female; D006801:Humans; D008175:Lung Neoplasms / Q000556:secondary; D008325:Mammary Neoplasms, Experimental / Q000378:metabolism* / Q000473:pathology*; D051379:Mice; D008807:Mice, Inbred BALB C; D016513:Mice, SCID; D009360:Neoplastic Cells, Circulating / Q000473:pathology*; D051381:Rats; D018719:Erb-b2 Receptor Tyrosine Kinases / Q000096:biosynthesis; D020893:Receptor, ErbB-3 / Q000096:biosynthesis*
chemical_list: D018719:Erb-b2 Receptor Tyrosine Kinases; D020893:Receptor, ErbB-3